CompoAtlas

Memory Boost

Memory Boost, licence 80110049: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Ginkgo 120 mg, Ginkgo Biloba, Ginkgo Biloba 120 mg
Licence holder
Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
NPN or DIN-HM
80110049
Status
Active licence
Licence date
20 May 2021
Revision date
13 August 2024
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ginkgo biloba

Source : Ginkgo biloba - feuille

Extract : Matériel brut sec

Extraction ratio : 50:1

Dry plant equivalent : 6000 mg

Potency : 24.0 % Flavonoid glycosides

120.0 mgNot calculated
Ginkgo biloba

Source : Ginkgo biloba - feuille

Potency : 6.0 % Terpene lactones

Not specifiedNot calculated

Non-medicinal ingredients

Poudre d'Oryza Sativa (Riz), Acide acétique, Dioxyde de silicium, Stéarate de magnésium, Lauryl sulfate de sodium, Gélatine, Phosphate dicalcique, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1.0 Capsule ; maximum: 2.0 Capsule1.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to enhance cognitive function and memory in adults. Helps to enhance cognitive function in adults. Helps to enhance memory in adults. Helps to support peripheral circulation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80110049

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2024. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line